Abstract
Morphometric image analysis enables the quantification of differences in the shape and size of organs between individuals. Here we have applied morphometric methods to the study of the liver by constructing surface meshes from liver segmentations from abdominal MRI images in 33,434 participants in the UK Biobank. Based on these three dimensional mesh vertices, we evaluated local shape variations and modelled their association with anthropometric, phenotypic and disease traits, including liver disease and type-2 diabetes. We found that age, body mass index, hepatic fat and iron content, as well as, health traits were significantly associated with regional liver shape and size. Interaction models in disease groups showed that the presence of type-2 diabetes accelerates age-related changes in the liver, while presence of liver fat further increased shape variation in both type-2 diabetes and liver disease. The results suggest that this novel approach may greatly benefit studies aiming at better categorisation of pathologies associated with acute and chronic liver conditions.
Competing Interest Statement
MC and EPS are employees of Calico Life Sciences LLC
Funding Statement
This research was funded by Calico Life Sciences LLC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Participant data from the UK Biobank cohort was obtained through UK Biobank Access Application number 44584. The UK Biobank has approval from the North West Multi-Centre Research Ethics Committee (REC reference: 11/NW/0382). All methods were performed in accordance with the relevant guidelines and regulations, and informed consent was obtained from all participants. Researchers may apply to use the UKBB data resource by submitting a health-related research proposal (https://www.ukbiobank.ac.uk).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Researchers may apply to use the UKBB data resource by submitting a health-related research proposal (https://www.ukbiobank.ac.uk).
Abbreviations
- T2D
- Type 2 Diabetes
- BMI
- Body mass index
- WHR
- waist-to-hip ratio
- AST:ALT
- ratio of aspartate aminotransferase to alanine aminotransferase
- FIB-4
- Fibrosis-4 index
- Liver PDFF
- Liver percentage density fat fraction
- MUR
- Mass univariate regression
- TFCE
- Threshold-free cluster enhancement
- SPMs
- Statistical parametric maps
- S2S
- Surface-to-surface
- PCA
- Principal component analysis